Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamza Celik

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Discovery|February 13, 2021
LKB1/<i>STK11</i> Is a Tumor Suppressor in the Progression of Myeloproliferative NeoplasmsChristian Marinaccio, Praveen Suraneni, Hamza Celik, et al.
The Journal of Clinical Investigation|May 16, 2019
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cellsDarja Karpova, Michael P Rettig, Julie Ritchey, et al.
Blood|September 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPNEdimara S Reis, Rebecca Buonpane, Hamza Celik, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Discovery|February 13, 2021
LKB1/<i>STK11</i> Is a Tumor Suppressor in the Progression of Myeloproliferative NeoplasmsChristian Marinaccio, Praveen Suraneni, Hamza Celik, et al.
The Journal of Clinical Investigation|May 16, 2019
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cellsDarja Karpova, Michael P Rettig, Julie Ritchey, et al.
Blood|September 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPNEdimara S Reis, Rebecca Buonpane, Hamza Celik, et al.
Pageof 3